ERBB2 and breast cancer: About 15% ~ 20% of breast cancers are TNBC, which lacks the expression of human epidermal growth factor receptor (HER2), progesterone receptor (PR) and oestrogen receptor (ER), strong aggressiveness, easy recurrence and high cell viability.2, 3, 4